|Bimekizumab for treating moderate to severe plaque psoriasis
|Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials.
|Therapeutic Advances in Chronic Disease
|Efficacy and safety of bimekizumab for the treatment of psoriasis: a systematic review and meta-analysis of randomized clinical trials.
|Journal of Dermatological Treatment
|Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials.
|Journal of the American Academy of Dermatology.
|Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
|The Cochrane database of systematic reviews.
|Anti-drug antibodies of IL-17 inhibitors for psoriasis: a systematic review.
|The Journal of dermatological treatment.
|Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis.
|Dermatol Ther (Heidelb)
|Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis.
|Dermatology and Therapy